Literature DB >> 2808483

Increased mutagenicity of N-nitrosodiethanolamine in human lymphocyte cultures after activation by alcohol dehydrogenase.

I Henn1, G Eisenbrand, H Zankl.   

Abstract

The effect of alcohol dehydrogenase (ADH/NAD) from yeast and horse liver was tested on the induction of chromosomal mutations and sister chromatid exchanges (SCE) by N-nitrosodiethanolamine (NDELA) in human lymphocyte cultures. BrdUrd (27 micrograms) was added 24 h after starting the cultures to allow visualisation of SCE. ADH/NAD and NDELA were added 24 h later in different concentrations. No significantly higher level of numerical or structural chromosome aberrations was observed. However, the SCE frequency per cell was significantly increased by adding NAD (31.25 mumol and 62.5 mumol). The exclusive addition of 220 units ADH from yeast as well as 1.8 units ADH from horse liver also raised the number of SCE highly significantly. The combination of NAD and ADH was more effective than each substances alone in the yeast but not in the horse liver system. NDELA in a range of 12.5-62.5 mumol, given to cultures with ADH/NAD from yeast, additionally increased the SCE frequencies in a dose-dependent way. Similar results were found in cultures containing ADH/NAD from horse liver and 6.25-31.25 mumol NDELA, but the total numbers of SCE were distinctly higher. These results indicate that NDELA is strongly activated by ADH from yeast but even more by ADH from horse liver.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2808483     DOI: 10.1007/bf00393334

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  17 in total

1.  Contamination of toiletries and cosmetic products with volatile and nonvolatile N-nitroso carcinogens.

Authors:  B Spiegelhalder; R Preussmann
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

2.  Biological activity of N-nitrosodiethanolamine and of potential metabolites which may arise after activation by alcohol dehydrogenase in Salmonella typhimurium, in mammalian cells, and in vivo.

Authors:  E Denkel; B L Pool; J R Schlehofer; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

3.  Alcoholdehydrogenase as an activating enzyme for N-nitrosodiethanolamine (NDELA): in vitro activation of NDELA to a potent mutagen in Salmonella typhimurium.

Authors:  G Eisenbrand; E Denkel; B Pool
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

4.  Potent carcinogenicity of nitrosodiethanolamine in rats.

Authors:  W Lijinsky; M D Reuber; W B Manning
Journal:  Nature       Date:  1980-12-11       Impact factor: 49.962

5.  Derivatives of side-chain hydroxylated nitrosamines direct acting mutagens in Salmonella typhimurium.

Authors:  C J Michejda; A W Andrews; S R Koepke
Journal:  Mutat Res       Date:  1979-08       Impact factor: 2.433

6.  N-nitrosodiethanolamine is activated in the rat to an ultimate genotoxic metabolite by sulfotransferase.

Authors:  W Sterzel; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  Penetration of rat skin by N-nitrosodiethanolamine and N-nitrosomorpholine.

Authors:  W Lijinsky; A M Losikoff; E B Sansone
Journal:  J Natl Cancer Inst       Date:  1981-01       Impact factor: 13.506

8.  Cytogenetic effects of N-nitrosodiethanolamine (NDELA) and NDELA-monoacetate in human lymphocytes.

Authors:  U Dittberner; G Eisenbrand; H Zankl
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

9.  The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium.

Authors:  W Lijinsky; A W Andrews
Journal:  Mutat Res       Date:  1983-10       Impact factor: 2.433

10.  Comparison of the mutagenic activity of dialkylnitrosamines in animal-mediated and in vitro assays using an Escherichia coli indicator.

Authors:  P Kerklaan; G Mohn; S Bouter
Journal:  Carcinogenesis       Date:  1981       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.